Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 15.02% | 5.92% | -16.38% | 32.89% | -2.40% |
| Total Depreciation and Amortization | -15.34% | -10.08% | -5.24% | -15.86% | -29.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -42.24% | 9.69% | 627.56% | -145.87% | 1,654.92% |
| Change in Net Operating Assets | 1,562.58% | 106.96% | -41.36% | -82.20% | -103.57% |
| Cash from Operations | 21.53% | 15.74% | -4.94% | -43.35% | -14.25% |
| Capital Expenditure | 100.00% | -1,681.82% | -653.85% | -989.47% | 88.97% |
| Sale of Property, Plant, and Equipment | 58.33% | 110.00% | -80.00% | -92.73% | -31.43% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 184.44% | -242.86% | -641.18% | -233.56% | -100.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -78.53% | -77.21% | -77.21% | 8,341.26% | 8,465.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -89.59% | -76.63% | -87.56% | -5.68% | -- |
| Cash from Financing | -61.86% | -77.39% | -78.11% | 1,636.01% | 10,092.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -402.09% | -359.25% | -357.68% | 105.48% | 127.56% |